|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor显示文摘 | Perzborn E Strassburger J Wilmen A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 2 | Preclinical and clinical characteristics of rivarraxaban:a novel,oral,direct factor Xa inhibitor显示文摘 | Laux V Perzborn E Kubitza D | | 0，，： | 1 |
| 3 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct factor Xa inhibitor 显示文摘 | Perzborn E Strassburger J Wilmen A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 4 | Rivaroxaban: a new oral factor Xa inhibitor 显示文摘 | Perzborn E Roehrig S Straub A | 2010 | Arterioscler Thromb Vasc Biol2010，30，： | 1 |
| 5 | Recombinant factor VIIA partially reverses the effects of the factor XA inhibitor rivaroxaban on thrombin generation, but not the effects of thrombin inhibitors, in vitro显示文摘 | Perzborn E Harwardt M | 2007 | J Thromb Haemost2007，5，2： | 1 |
| 6 | Rivaroxaban: a new oral factor Xa inhibitor 显示文摘 | Perzborn E Roehrig S Straub A | 2010 | Arterioscler Thromb Vasc Biol2010，30，3： | 1 |
| 7 | The discovery and development of rivaroxaban显示文摘 | MISSELWITZ F BERKOWITZ SD PERZBORN E | 2011 | Ann N Y Acad Sci2011，1222，： | 1 |
| 8 | In vitro and in vivo studies of the novel antithrombotic agent BAY 597939-an oral, direct factor Xa inhibitor显示文摘 | PERZBORN E STRASSBURGER J WILMEN A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 9 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939 an oral, direct factor X a inhibitor 显示文摘 | Perzborn E Strassburger J Wilmen A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 10 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939- an oral , direct factor Xa inhibitor显示文摘 | PERZBORN E STRASSBURGER J WILMEN A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 11 | Rivaroxaban:A New Oral Factor Xa Inhibitor显示文摘 | Perzborn E Roehfig S Straub A | 2010 | Arteriosclerosis thrombosis and vascular biology2010，30，3： | 1 |
| 12 | In vitro and in vivo, studies of the novel antithrombotic agent BAY 59 - 7939- an o- ral,direct factor X a inhibitor显示文摘 | Perzborn E Strassburger J Wilmen A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 13 | Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor 显示文摘 | Laux V Perzborn E | 2007 | Semin ThrombHemost2007，33，5： | 1 |
| 14 | In vitro and in vivo studies of the novel antithrombotic agent BAY-59-7939-an oral, direct factor Xa inhibitor 显示文摘 | Perzborn E Strassburger J Wilm en A | 2005 | J Thromb Haemosi2005，3，3： | 1 |
| 15 | Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral,direct factor Xa inhibitor显示文摘 | Biemond BJ Perzborn E Friederich PW | | 0，，03： | 1 |
| 16 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939 - an oral, direct Factor Xa inhibitor显示文摘 | Perzborn E Strassburger J Wilmen A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 17 | The discovery and develop- ment of rivaroxaban, an oral, direct factor Xa inhibitor显示文摘 | Perzborn E Roehrig S Straub A | 2011 | Nat Rev Drug Discov2011，10，1： | 1 |
| 18 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59- 7939-an oral, direct factor Xa inhibitor显示文摘 | PERZBORN E STRASSBURGER J WILMEN A | 2005 | J Thromb Haemost2005，3，3： | 1 |
| 19 | Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) - an oral, direct factor Xa inhibitor 显示文摘 | Biemond BJ Perzborn E Friederich PW | 2007 | Thromb Haemost2007，97，3： | 1 |
| 20 | In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939-an oral, direct factor Xa inhibitor显示文摘 | Perzborn E Strassburger J Wilmen A | 2005 | J Thromb Haemost2005，3，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员